Specialized and general physicians show significant gaps in diagnosing skin diseases across skin tones, with deep learning assistance improving accuracy but also highlighting disparities.
Repare bags $40m from Roche as solid tumour trial begins – Pharmaceutical Technology
Share this article Repare is eligible to up to $1.2bn from Roche. Credit: Bonsales via Shutterstock. Repare Therapeutics announced the receipt of a $40m milestone